TROP-2 is generally expressed in normal tissues at a low level but overexpressed in certain epithelial tumors.74 About 80% of breast cancers have a high-TROP-2 expression, especially HR+/HER2 negative and TNBC.75-77. Here, TACSTD2 is linked to breast cancer.